Classic Thinking

Just when it looked like the FDA was living in the 21st century the agency issues new guidance for …wait for it …. Blood Glucose Monitors. Now we know that BGM is dying a slow and profitable death, but it is dying and there is no hope for long term survival. So naturally it makes perfect sense that the agency spends valuable time and resources to come up with new guidelines when in place will be meaningless as the industry, they were designed for will be dead.

We shouldn’t be too hard on the FDA as they are making progress . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.